M. Cecilia Lansang

2.6k total citations · 1 hit paper
77 papers, 1.5k citations indexed

About

M. Cecilia Lansang is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, M. Cecilia Lansang has authored 77 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Endocrinology, Diabetes and Metabolism, 17 papers in Cardiology and Cardiovascular Medicine and 15 papers in Surgery. Recurrent topics in M. Cecilia Lansang's work include Hyperglycemia and glycemic control in critically ill and hospitalized patients (25 papers), Diabetes Management and Research (24 papers) and Diabetes Treatment and Management (17 papers). M. Cecilia Lansang is often cited by papers focused on Hyperglycemia and glycemic control in critically ill and hospitalized patients (25 papers), Diabetes Management and Research (24 papers) and Diabetes Treatment and Management (17 papers). M. Cecilia Lansang collaborates with scholars based in United States, United Kingdom and Malaysia. M. Cecilia Lansang's co-authors include Norman K. Hollenberg, Deborah A. Price, Guillermo E. Umpierrez, Naomi D.L. Fisher, Francisco J. Pasquel, Ketan Dhatariya, Lori M. Laffel, Suzette Y. Osei, Gordon H. Williams and Laurence Kennedy and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

M. Cecilia Lansang

74 papers receiving 1.5k citations

Hit Papers

Management of diabetes and hyperglycaemia in the hospital 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Cecilia Lansang United States 22 852 380 239 188 179 77 1.5k
Tore Julsrud Berg Norway 21 985 1.2× 382 1.0× 221 0.9× 164 0.9× 218 1.2× 83 2.1k
Helen L. Lutgers Netherlands 28 783 0.9× 357 0.9× 244 1.0× 173 0.9× 219 1.2× 46 2.4k
Di̇lek Gogas Yavuz Türkiye 23 818 1.0× 373 1.0× 341 1.4× 119 0.6× 211 1.2× 147 2.0k
Antonio Barbato Italy 21 479 0.6× 435 1.1× 369 1.5× 225 1.2× 184 1.0× 55 1.7k
Andromachi Vryonidou Greece 22 805 0.9× 283 0.7× 339 1.4× 138 0.7× 292 1.6× 67 1.9k
Gareth Dunseath United Kingdom 23 1.0k 1.2× 245 0.6× 462 1.9× 316 1.7× 287 1.6× 77 1.8k
Oğuzhan Deyneli Türkiye 20 671 0.8× 342 0.9× 312 1.3× 100 0.5× 148 0.8× 63 1.7k
Milla Rosengård‐Bärlund Finland 20 970 1.1× 550 1.4× 328 1.4× 373 2.0× 157 0.9× 31 1.8k
Lorenza Santi Italy 14 625 0.7× 293 0.8× 187 0.8× 66 0.4× 215 1.2× 23 1.3k

Countries citing papers authored by M. Cecilia Lansang

Since Specialization
Citations

This map shows the geographic impact of M. Cecilia Lansang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Cecilia Lansang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Cecilia Lansang more than expected).

Fields of papers citing papers by M. Cecilia Lansang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Cecilia Lansang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Cecilia Lansang. The network helps show where M. Cecilia Lansang may publish in the future.

Co-authorship network of co-authors of M. Cecilia Lansang

This figure shows the co-authorship network connecting the top 25 collaborators of M. Cecilia Lansang. A scholar is included among the top collaborators of M. Cecilia Lansang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Cecilia Lansang. M. Cecilia Lansang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eltemamy, Mohamed, Paul Oh, Yi‐Chia Lin, et al.. (2024). Implementation of a Comprehensive Protocol for Enhanced Recovery After Surgery (ERAS) in Kidney Transplant Recipients Improves Patient and Graft Outcomes. Clinical Transplantation. 39(1). e70056–e70056. 1 indexed citations
3.
Morey‐Vargas, Oscar L., Ali Aminian, Karen Steckner, et al.. (2022). Perioperative management of diabetes in patients undergoing bariatric and metabolic surgery: a narrative review and the Cleveland Clinic practical recommendations. Surgery for Obesity and Related Diseases. 18(8). 1087–1101. 6 indexed citations
5.
Griebeler, Marcio L., et al.. (2021). The importance of implementing inpatient virtual coverage in an endocrinology practice: lessons learned thus far from the COVID-19 pandemic. SHILAP Revista de lepidopterología. 7(1). 5–5. 3 indexed citations
6.
Lansang, M. Cecilia, et al.. (2021). Inpatient Hyperglycemia and Transitions of Care: A Systematic Review. Endocrine Practice. 27(4). 370–377. 3 indexed citations
7.
Burguera, Bartolomé, Kevin M. Pantalone, Marcio L. Griebeler, et al.. (2020). The Need And Benefit of Implementing Telemedicine in Clinical Practice. Endocrine Practice. 26(7). 794–796. 4 indexed citations
8.
Li, Manshi, et al.. (2020). Causes of diabetic ketoacidosis among adults with type 1 diabetes mellitus: insulin pump users and non-users. BMJ Open Diabetes Research & Care. 8(2). e001329–e001329. 28 indexed citations
9.
Pasquel, Francisco J., M. Cecilia Lansang, Maria A. Urrutia, et al.. (2020). A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients With Type 2 Diabetes: Glargine U300 Hospital Trial. Diabetes Care. 43(6). 1242–1248. 23 indexed citations
10.
Lansang, M. Cecilia, et al.. (2020). The role of SGLT-2 inhibitors in managing type 2 diabetes. Cleveland Clinic Journal of Medicine. 88(1). 47–58. 19 indexed citations
11.
Lansang, M. Cecilia, et al.. (2019). Diabetes management: Beyond hemoglobin A1c. Cleveland Clinic Journal of Medicine. 86(9). 595–600. 3 indexed citations
12.
Lansang, M. Cecilia, et al.. (2018). Diabetic Myonecrosis: A Diagnostic and Treatment Challenge in Longstanding Diabetes. Case Reports in Endocrinology. 2018. 1–4. 8 indexed citations
13.
Hanipah, Zubaidah Nor, Suriya Punchai, M. Cecilia Lansang, et al.. (2018). Clinical features of symptomatic hypoglycemia observed after bariatric surgery. Surgery for Obesity and Related Diseases. 14(9). 1335–1339. 8 indexed citations
15.
Song, Anne, Farah Naz Rahman, James Bena, et al.. (2017). Transitioning from intravenous to subcutaneous insulin in the medical intensive care unit. Diabetes Research and Clinical Practice. 134. 199–205. 3 indexed citations
16.
Lansang, M. Cecilia, et al.. (2015). U-500 Regular Insulin Use in Hospitalized Patients. Endocrine Practice. 21(1). 54–58. 12 indexed citations
17.
Meier‐Kriesche, Herwig‐Ulf, et al.. (2010). Association between Admission Hyperglycemia and Length of Stay after Renal Transplantation. Endocrine Practice. 16(5). 805–809. 5 indexed citations
18.
Lansang, M. Cecilia & Guillermo E. Umpierrez. (2008). Management of Inpatient Hyperglycemia in Noncritically Ill Patients. Diabetes Spectrum. 21(4). 248–255. 13 indexed citations
19.
Hollenberg, Norman K., Deborah A. Price, Naomi D.L. Fisher, et al.. (2003). Glomerular hemodynamics and the renin-angiotensin system in patients with type 1 diabetes mellitus. Kidney International. 63(1). 172–178. 98 indexed citations
20.
Lansang, M. Cecilia, Deborah A. Price, Lori M. Laffel, et al.. (2001). Renal vascular responses to captopril and to candesartan in patients with type 1 diabetes mellitus. Kidney International. 59(4). 1432–1438. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026